TWP
PFE icon

Treybourne Wealth Planners’s Pfizer PFE Stock Holding History

Treybourne Wealth Planners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		$389K Sell
9,933
-777
-7% -$30.2K 0.24% 32
2021
Q1 		$388K Sell
10,710
-1,004
-9% -$35.6K 0.27% 29
2020
Q4 		$431K Buy
+11,714
New +$430K 0.31% 26

Other funds holding PFE

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Treybourne Wealth Planners's PFE Position: Q2 2021 in Review

Treybourne Wealth Planners reduced its Pfizer (PFE) stake by 7.3% in Q2 2021, selling an estimated $30.2K and leaving 9,933 shares worth $389K. The position accounts for 0.24% of the portfolio, ranked #32.

Treybourne Wealth Planners first reported a position in PFE in Q4 2020 and has held it in 3 quarters since. The position peaked at $431K in Q4 2020. 2,732 funds tracked by Wall St. Rank hold PFE as of Q2 2021.

  • Treybourne Wealth Planners held 9,933 shares of Pfizer worth $389K as of Q2 2021.
  • Treybourne Wealth Planners sold 777 Pfizer shares in Q2 2021, an estimated $30.2K.
  • Pfizer made up 0.24% of Treybourne Wealth Planners's portfolio in Q2 2021, its #32 holding.
  • Treybourne Wealth Planners first reported a position in Pfizer in Q4 2020 and has held it in 3 quarters since.
  • Treybourne Wealth Planners's Pfizer position peaked at $431K in Q4 2020.
  • 2,732 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.

Based on Treybourne Wealth Planners's 13F filing for Q2 2021, filed 29 Jul 2021.